Sino Biopharmaceutical Li...

PNK: SBHMY · Real-Time Price · USD
9.75
-0.55 (-5.34%)
At close: May 07, 2025, 3:16 PM

Sino Biopharmaceutical Statistics

Share Statistics

Sino Biopharmaceutical has 894.68M shares outstanding. The number of shares has increased by 1.42% in one year.

Shares Outstanding 894.68M
Shares Change (YoY) 1.42%
Shares Change (QoQ) 1.42%
Owned by Institutions (%) n/a
Shares Floating n/a
Failed to Deliver (FTD) Shares 14
FTD / Avg. Volume 17.95%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is 29.02 and the forward PE ratio is null. Sino Biopharmaceutical's PEG ratio is 1.09.

PE Ratio 29.02
Forward PE n/a
PS Ratio 3.52
Forward PS n/a
PB Ratio 3.18
P/FCF Ratio 0
PEG Ratio 1.09
Financial Ratio History

Enterprise Valuation

Sino Biopharmaceutical has an Enterprise Value (EV) of 2,031.4B.

EV / Sales 70.37
EV / EBITDA 332.54
EV / EBIT 0
EV / FCF 0

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.31.

Current Ratio 1.26
Quick Ratio 1.14
Debt / Equity 0.31
Debt / EBITDA 1.6
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is 10.95% and Return on Invested Capital is 10.63%.

Return on Equity 10.95%
Return on Assets 5.35%
Return on Invested Capital 10.63%
Revenue Per Employee $1,184,058.37
Profits Per Employee $143,559.37
Employee Count 24,379
Asset Turnover 0.44
Inventory Turnover 2.25

Taxes

Income Tax 492.92M
Effective Tax Rate 9.34%

Stock Price Statistics

The stock price has increased by 31.67% in the last 52 weeks. The beta is 0.73, so Sino Biopharmaceutical's price volatility has been higher than the market average.

Beta 0.73
52-Week Price Change 31.67%
50-Day Moving Average 8.84
200-Day Moving Average 8.31
Relative Strength Index (RSI) 64.18
Average Volume (20 Days) 78

Income Statement

In the last 12 months, Sino Biopharmaceutical had revenue of 28.87B and earned 3.5B in profits. Earnings per share was 2.

Revenue 28.87B
Gross Profit 23.53B
Operating Income 6.28B
Net Income 3.5B
EBITDA 6.11B
EBIT 5.17B
Earnings Per Share (EPS) 2
Full Income Statement

Balance Sheet

The company has 9.57B in cash and 9.78B in debt, giving a net cash position of -214.26M.

Cash & Cash Equivalents 9.57B
Total Debt 9.78B
Net Cash -214.26M
Retained Earnings n/a
Total Assets 65.41B
Working Capital 5.13B
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share 0
Full Cash Flow Statement

Margins

Gross margin is 81.51%, with operating and profit margins of 21.76% and 12.12%.

Gross Margin 81.51%
Operating Margin 21.76%
Pretax Margin 18.28%
Profit Margin 12.12%
EBITDA Margin 21.16%
EBIT Margin 21.76%
FCF Margin n/a

Dividends & Yields

SBHMY pays an annual dividend of $0.21, which amounts to a dividend yield of 1.93%.

Dividend Per Share $0.21
Dividend Yield 1.93%
Dividend Growth (YoY) -49.99%
Payout Ratio 70.76%
Earnings Yield 3.45%
FCF Yield 0%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for SBHMY.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Sep 4, 2020. It was a forward split with a ratio of 3:2.

Last Split Date Sep 4, 2020
Split Type forward
Split Ratio 3:2

Scores

Altman Z-Score 1.04
Piotroski F-Score 6